Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | IBI3001 |
Trade Name | |
Synonyms | IBI-3001|IBI 3001 |
Drug Descriptions |
IBI3001 is an antibody-drug conjugate (ADC) comprising a bispecific antibody targeting CD276 (B7-H3) and EGFR linked to Exatecan, which potentially decreases tumor growth (Cancer Res (2024) 84 (7_Supplement): LB055). |
DrugClasses | CD276 Antibody 13 EGFR Antibody 57 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IBI3001 | IBI3001 | 0 | 1 |